The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.

Ninety-three percent of hospitals responding to a recent survey conducted by 340B Health said they would struggle to maintain current levels of uncompensated care in the wake of drugmakers’ proposed ...